As shown in Figure S6, 4 weeks TAC did not increase the hepatic fibrosis status (as demonstrated by the expression levels of collagen 1 and TGFβ), nor the inflammatory status of the liver (as shown by IL-6, TNF-α, F4/80 and CCL2 expression levels). This evidence concerns the gene CCL2 and Hepatic fibrosis.